ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Maryland » Geriatric Medicine

Top Geriatric Medicine Prescribers in Maryland

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
LOVEEN PUTHUMANA M.D.

Geriatric Medicine

3,874

$207K

291
291 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $59

RODOLFO FERNANDEZ M.D.

Geriatric Medicine

3,498

$263K

114
96 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 24%

$75
Average prescription price

Avg: $59

PETER SCHISSLER M.D.

Geriatric Medicine

3,410

$165K

157
131 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $59

BENJAMIN AVRUNIN M.D.

Geriatric Medicine

3,397

$203K

213
189 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 24%

$60
Average prescription price

Avg: $59

KURUPPUNAYAKE DHARMASENA M.D.

Geriatric Medicine

3,342

$232K

188
145 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

16%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $59

VICTORIA VANIK M.D.

Geriatric Medicine

3,135

$173K

298
291 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $59

JEREMY BARRON M.D.

Geriatric Medicine

3,019

$185K

226
223 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

6%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $59

ANDREW KUNDRAT M.D.

Geriatric Medicine

2,993

$183K

243
243 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $59

PAMELA AUNG MD

Geriatric Medicine

2,768

$186K

122
79 are 65+

17%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 24%

$67
Average prescription price

Avg: $59

DON YABLONOWITZ M.D.

Geriatric Medicine

2,734

$181K

157
136 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 24%

$66
Average prescription price

Avg: $59

MARY MACGREGOR M.D.

Geriatric Medicine

2,553

$80.8K

77
76 are 65+

16%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 24%

$32
Average prescription price

Avg: $59

GLORIA DAMIEN M.D.

Geriatric Medicine

2,532

$205K

140
111 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 24%

$81
Average prescription price

Avg: $59

STEPHANIE TRIFOGLIO M.D.

Geriatric Medicine

2,388

$176K

156
137 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 24%

$74
Average prescription price

Avg: $59

MARGUERITE MORAN M.D.

Geriatric Medicine

2,364

$213K

121
113 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 24%

$90
Average prescription price

Avg: $59

STEVEN BILLET M.D.

Geriatric Medicine

2,077

$178K

94
83 are 65+

17%
patients receiving schedule two controlled substances

Avg: 7%

22%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 24%

$86
Average prescription price

Avg: $59

JEANNE ASHER M.D.

Geriatric Medicine

2,018

$178K

148
141 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 24%

$88
Average prescription price

Avg: $59

STUART TURKEWITZ MD

Geriatric Medicine

1,976

$115K

118
104 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $59

SUSAN MILLER M.D.

Geriatric Medicine

1,683

$71.3K

65
63 are 65+

20%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 24%

$42
Average prescription price

Avg: $59

SWARUPA ESANAKULA M.D.

Geriatric Medicine

1,633

$79.4K

25
24 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $59

BO ZAW WIN M.D.

Geriatric Medicine

1,631

$111K

109
98 are 65+

17%
patients receiving schedule two controlled substances

Avg: 7%

16%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 24%

$68
Average prescription price

Avg: $59

JENNIFER HAYASHI M.D.

Geriatric Medicine

1,618

$87.4K

92
89 are 65+

15%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $59

PAUL SCHWARTZ M.D.

Geriatric Medicine

1,602

$110K

89
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $59

ZEBA GELOO MD

Geriatric Medicine

1,587

$132K

188
100 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 24%

$83
Average prescription price

Avg: $59

RUTH KEVESS-COHEN M.D.

Geriatric Medicine

1,466

$95.9K

147
124 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 24%

$65
Average prescription price

Avg: $59

DANELLE CAYEA M.D.

Geriatric Medicine

1,429

$78.2K

56
56 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $59

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank